ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Budget Timetable Puts Pressure On Congress To Complete Appropriations Before Oct. 1

January 30, 1976

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery

April 20, 1990

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012